2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow CP 4126: new trials by email Literature Review of CP 4126 trials Research Report on CP 4126
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin CO-1.01 and Cisplatin - Solid Tumor, Non-small-cell Lung Cancer | Phase 1 | Terminated | Clovis Oncology, Inc. | 8 | 2012-07-01 | 2014-03-11 |
| A Study of CP-4126 in Patients With Advanced Pancreatic Cancer IV CP-4126 - Advanced Adenocarcinoma of Pancreas | Phase 2 | Completed | Clavis Pharma | 21 | 2009-04-01 | 2012-02-10 |
| A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour CP-4126, Gemcitabine - Solid Tumors | Phase 1 | Completed | Clavis Pharma | 26 | 2008-10-01 | 2010-09-06 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Clavis Pharma (2) · Clovis Oncology, Inc. (1)
Belgium (2) · Netherlands (1) · Norway (1) · United Kingdom (1) · United States (1)